- Home
- / Rottendorf Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Rottendorf Pharma financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
€166.9 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 103.5M | 128.5M | 166.9M |
| Cost of goods sold | 23.7M | 29.0M | 43.1M |
| Gross profit | 79.9M | 99.5M | 123.8M |
| Gross profit margin, % | 77.2% | 77.4% | 74.2% |
| General and administrative expense | 26.7M | 56.5M | 63.8M |
| Operating expense total | 75.6M | 84.9M | 95.4M |
| Depreciation and amortization | 2.8M | 3.3M | 3.8M |
| Interest income | 47.1K | 52.1K | 131.7K |
| Interest expense | 399.1K | 244.5K | 266.3K |
| Income tax expense | 1.8M | 4.8M | 11.1M |
| Net Income | 3.8M | 10.4M | 24.8M |